HHS-NIH11 Grants
35 open or forecasted grant opportunities from the HHS-NIH11. Ranked by our fit-and-eligibility score for small nonprofits, schools, and community organizations. Updated daily from Simpler.Grants.gov.
- HHS-NIH11 · community developmentLimited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial OptionalDeadline 2026-08-02 · Up to $850,000 · Fit 87/100The National Human Genome Research Institute (NHGRI) seeks to broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in research addressing the ethical, legal and social implications (ELSI) of advances in human...
- HHS-NIH11 · community developmentSingle Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)Deadline 2026-09-30 · Up to $1,500,000 · Fit 79/100This Notice of Funding Opportunity (NOFO) invites a single cooperative agreement application for the Resource Center for the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D). The purpose of CaRe-T1D is to support innovative, discovery and...
- HHS-NIH11 · community developmentNCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)Deadline 2026-09-18 · Not listed · Fit 79/100This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject...
- HHS-NIH11 · community developmentNCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)Deadline 2026-09-18 · Not listed · Fit 78/100This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject...
- HHS-NIH11 · healthNIH Director’s New Innovator Award (DP2 Clinical Trial Optional)Deadline 2026-08-17 · $475,000 · Fit 77/100The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of...
- HHS-NIH11 · healthGlobal Infectious Disease Research Training Program (D43 Clinical Trial Optional)Deadline 2026-08-06 · Not listed · Fit 75/100This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative...
- HHS-NIH11 · community developmentPopulation Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)Deadline 2026-10-30 · Not listed · Fit 75/100The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with...
- HHS-NIH11 · uncategorizedNIH Director’s Pioneer Award (DP1 Clinical Trial Optional)Deadline 2026-09-09 · $700,000 · Fit 74/100The NIH Director"s Pioneer Award supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To be...
- HHS-NIH11 · community developmentIntervention Research to Improve Native American Health (R34 Clinical Trial Optional)Deadline 2027-01-07 · Not listed · Fit 73/100<p>The purpose of this notice of funding opportunity (NOFO) is to support research on interventions to improve health in Native American (NA) populations. This includes 1) etiologic research, where there is a significant gap in knowledge, that will...
- HHS-NIH11 · environmentSocial disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)Deadline 2026-09-07 · Not listed · Fit 71/100This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in...
- HHS-NIH11 · environmentMaximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)Deadline 2026-12-02 · Not listed · Fit 69/100This NOFO seeks to advance research and training in high-priority areas of child health by stimulating the use of Environmental Influences on Child Health Outcomes (ECHO) Cohort data by postdoctoral fellows from relevant scientific disciplines. This RFA...
- HHS-NIH11 · uncategorizedCCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)Deadline 2026-10-16 · Up to $300,000 · Fit 68/100This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used...
- HHS-NIH11 · uncategorizedNIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)Deadline 2026-07-13 · Not listed · Fit 68/100<p>The purpose of the NIA Career Transition Award (CTA) is to facilitate the transition of mentored researchers to tenure-track faculty conducting research that advances the mission of NIA. This three-year award provides protected time through salary and...
- HHS-NIH11 · healthEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)Deadline 2026-11-18 · Not listed · Fit 66/100<p>The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either...
- HHS-NIH11 · healthInvestigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)Deadline 2026-11-17 · Not listed · Fit 66/100<p>This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH-...
- HHS-NIH11 · environmentSocial disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)Deadline 2026-09-07 · Not listed · Fit 66/100This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in...
- HHS-NIH11 · healthAssay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)Deadline 2026-09-07 · Not listed · Fit 66/100Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists...
- HHS-NIH11 · healthTobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)Deadline 2026-07-14 · Up to $75,000 · Fit 65/100This Notice of Funding Opportunity (NOFO) aims to support new biomedical, behavioral, and social science investigators who are in the early stages of establishing independent careers in tobacco regulatory research. The R03 grant mechanism supports...
- HHS-NIH11 · healthFeasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)Deadline 2026-11-17 · Not listed · Fit 65/100<p>The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions...
- HHS-NIH11 · uncategorizedBRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)Deadline 2026-09-28 · Not listed · Fit 63/100The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the...
- HHS-NIH11 · uncategorizedClinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)Deadline 2026-11-02 · Not listed · Fit 63/100This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link:...
- HHS-NIH11 · uncategorizedMechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)Deadline 2027-01-07 · Not listed · Fit 63/100The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact...
- HHS-NIH11 · uncategorizedNHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)Deadline 2027-01-07 · Not listed · Fit 63/100The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting...
- HHS-NIH11 · uncategorizedDeveloping novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)Deadline 2026-11-05 · Not listed · Fit 63/100The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations....
- HHS-NIH11 · uncategorizedPopulation Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)Deadline 2027-01-07 · Not listed · Fit 63/100<p>This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol...
- HHS-NIH11 · uncategorizedSchizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)Deadline 2026-09-07 · Not listed · Fit 63/100Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood....
- HHS-NIH11 · uncategorizedAdvancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)Deadline 2026-07-16 · Not listed · Fit 55/100<p>The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority...
- HHS-NIH11 · healthLimited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)Deadline 2026-09-25 · Not listed · Fit 44/100<p>This funding opportunity announcement (FOA) encourages grant applications that support the activities of the National Primate Research Centers (NPRCs). Nonhuman primates (NHPs) are most closely related to humans, both physiologically and genetically....
- HHS-NIH11 · uncategorizedLimited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)Deadline 2026-09-25 · Not listed · Fit 44/100<p>The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus...
- HHS-NIH11 · healthClosedThe Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)Closed 2026-06-30 · Not listed · Fit 78/100Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the...
- HHS-NIH11 · healthClosedBRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)Closed 2026-06-15 · Up to $200,000 · Fit 77/100A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some...
- HHS-NIH11 · healthClosedBRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)Closed 2026-06-17 · Not listed · Fit 71/100The goal of this concept is to increase the impact of the BRAIN Initiative by targeted dissemination and integration of validated BRAIN Initiative tools to investigators at institutions that historically have not been major recipients of NIH support. This...
- HHS-NIH11 · uncategorizedClosedTuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)Closed 2026-07-10 · Up to $600,000 · Fit 60/100The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze...
- HHS-NIH11 · uncategorizedClosedNINDS Child Neurology Career Development Program (CNCDP) (K12 - Clinical Trial Not Allowed)Closed 2026-07-10 · Not listed · Fit 58/100The purpose of the NINDS Child Neurology Career Development Program (CNCDP) is to facilitate and support the research career development of physicians specialized in Child Neurology who have made a commitment to independent research careers. The CNCDP is a...
- HHS-NIH11 · healthClosedHEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study – Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed)Closed 2026-07-10 · Not listed · Fit 53/100This is a Notice of Funding Opportunity (NOFO) is for a Limited Competition that will invite applications from eligible organizations to apply. Please see Section III. Eligibility, for additional information. In accordance with NIH standard peer-review...